Durvalumab as Maintenance in Patients Who Received Chemoradiotherapy for Unresectable Stage III NSCLC: Real World Data From an Expanded Access Program in Brazil

Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC

NCT06223711 ·Status: RECRUITING ·Phase: PHASE2

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

NCT04642469 ·Status: COMPLETED ·Phase: PHASE3

Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC

NCT06998719 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

NCT05211895 ·Status: RECRUITING ·Phase: PHASE3

Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC

NCT05157542 ·Status: UNKNOWN ·Phase: PHASE1

Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung Cancer

NCT06564870 ·Status: ACTIVE_NOT_RECRUITING

Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer

NCT03519971 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)

NCT07050472 ·Status: COMPLETED

A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients

NCT03706690 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)

NCT03319316 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

NCT03693300 ·Status: COMPLETED ·Phase: PHASE2

Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy

NCT05267392 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC

NCT03822351 ·Status: COMPLETED ·Phase: PHASE2

Immune Profiling of Stage III Non-small Cell Lung Cancer Patients Treated With Concurrent Chemoradiation and Adjuvant Durvalumab: A Prospective Observational Phase II Trial

NCT04432142 ·Status: ACTIVE_NOT_RECRUITING

Lung Cancer With Copanlisib and Durvalumab

NCT04895579 ·Status: COMPLETED ·Phase: PHASE1

Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC.

NCT05128630 ·Status: RECRUITING ·Phase: PHASE2

Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLC

NCT03694236 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer

NCT03871153 ·Status: TERMINATED ·Phase: PHASE2

Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT

NCT07309211 ·Status: RECRUITING

Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC

NCT03130764 ·Status: WITHDRAWN ·Phase: PHASE2

Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)

NCT04449861 ·Status: COMPLETED ·Phase: PHASE3

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

NCT04026412 ·Status: COMPLETED ·Phase: PHASE3

Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer

NCT05696782 ·Status: RECRUITING ·Phase: PHASE2

Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736)

NCT03446547 ·Status: COMPLETED ·Phase: PHASE2

Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer

NCT03916419 ·Status: COMPLETED ·Phase: PHASE2